PDSS1

Across TCGA pan-cancer cohorts, PDSS1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PDSS1 data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher PDSS1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated PDSS1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

CCRCC, LUAD, and LSCC are the cancer types where PDSS1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	IV	0.221	0.961	.024	10	view →
LUAD	DFS	Median	All	0.841	0.917	.027	7	view →
LSCC	DFS	Median	III,IV	0.823	0.409	.038	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PDSS1–CCRCC (DFS)

Open the CCRCC breakdown →